Erica L. Monaco - 09 Dec 2021 Form 4/A - Amendment Insider Report for Biofrontera Inc. (BFRI)

Role
Chief Executive Officer
Signature
/s/ Erica L. Monaco
Issuer symbol
BFRI
Transactions as of
09 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
19 Jan 2022, 20:07:24 UTC
Date Of Original Report
13 Dec 2021
Previous filing
28 Oct 2021
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award $0 +56,689 $0.000000 56,689 09 Dec 2021 Common Stock 56,689 $4.77 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's Form 4 filed with the SEC on December 13, 2021 inadvertently reported an incorrect exercise price with respect to the Employee stock option (right to buy).
F2 The option vests in three equal annual installments beginning on December 9, 2022.